A Tertiary Care Center's Experience with Andexanet Alfa for Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage

被引：0
|
作者：
Smith, Matthew [1 ,2 ]
Beatty, Julia [3 ]
Keegan, Shaun [3 ,4 ]
Robinson, David [4 ]
Walsh, Kyle [2 ,4 ,5 ]
Garber, Paige [3 ]
机构：
[1] Univ Cincinnati, Neurol, Cincinnati, OH USA
[2] Gardner Neurosci Inst, Cincinnati, OH USA
[3] James L Winkle Coll Pharm, Cincinnati, OH USA
[4] Div Neurocrit Care, Cincinnati, OH USA
[5] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.9-008
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National Survey
    Fasanya, Charles
    Arrillaga, Abenamar
    Caronia, Catherine
    Rothburd, Lauren
    Japhe, Tenzing
    Hahn, Younghee
    Joseph, Paul
    Reci, Dajana
    Eckardt, Patricia
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [42] Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies
    Escolar, G.
    Diaz-Ricart, M.
    Arellano-Rodrigo, E.
    DRUGS OF TODAY, 2017, 53 (05) : 271 - 282
  • [43] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [44] Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds
    Jason J. Keinath
    Jona Lekura
    Christian D. Hauser
    Manisha K. Bajwa
    Michael E. Bloome
    James S. Kalus
    Mathew C. Jones
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 315 - 322
  • [45] Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds
    Keinath, Jason J.
    Lekura, Jona
    Hauser, Christian D.
    Bajwa, Manisha K.
    Bloome, Michael E.
    Kalus, James S.
    Jones, Mathew C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (02) : 315 - 322
  • [46] Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent
    Levy, Jerrold H.
    Connors, Jean M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (01) : 265 - 266
  • [47] Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
    Stevens, Victoria M.
    Trujillo, Toby C.
    Kiser, Tyree H.
    MacLaren, Robert
    Reynolds, Paul M.
    Mueller, Scott W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [48] Utilization and Laboratory Monitoring of Andexanet Alfa Reversal of Factor Xa Inhibitors in Bleeding Patients
    Alipour, Zahra
    Jackups, Ronald
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S17 - S18
  • [49] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298
  • [50] Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Connolly, Stuart J.
    Milling, Truman J., Jr.
    Eikelboom, John W.
    Gibson, C. Michael
    Curnutte, John T.
    Gold, Alex
    Bronson, Michele D.
    Lu, Genmin
    Conley, Pamela B.
    Verhamme, Peter
    Schmidt, Jeannot
    Middeldorp, Saskia
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Albaladejo, Pierre
    Lopez-Sendon, Jose
    Goodman, Shelly
    Leeds, Janet
    Wiens, Brian L.
    Siegal, Deborah M.
    Zotova, Elena
    Meeks, Brandi
    Nakamya, Juliet
    Lim, W. Ting
    Crowther, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (12): : 1131 - 1141
12345